Prostate Cancer
Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer - Abstract
February 7, 2011
Active surveillance for localized prostate cancer--current practices and recommendations - Abstract
February 4, 2011
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity - Abstract
February 4, 2011
Initial treatment costs of organ-confined prostate cancer: A general perspective - Abstract
February 4, 2011
Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zone - Abstract
February 4, 2011
Prostate cancer: Comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map - Abstract
February 4, 2011
Spirituality and end-of-life care in disadvantaged men dying of prostate cancer - Abstract
February 4, 2011
Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer- Abstract
February 3, 2011
Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans - Abstract
February 3, 2011
Editor's Commentary - Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
February 2, 2011
Abiraterone acetate significantly improved overall survival for patients with metastatic advanced prostate cancer
October 11, 2010
Study of investigational agent abiraterone acetate for metastatic advanced prostate cancer unblinded after meeting pre-determined criteria
September 10, 2010
Abiraterone acetate: A promising drug for the treatment of castration-resistant prostate cancer - Abstract
May 27, 2010